Agranulocytosis, plasmacytosis, and thrombocytosis due to methimazole-induced bone marrow toxicity.
Oh
Eun-Jee
EJ
Chae
Hyo-Jin
HJ
Park
Yeon-Joon
YJ
Park
Jong-Won
JW
Han
Kyungja
K
D000328:Adult; D000380:Agranulocytosis / Q000139:chemically induced* / Q000188:drug therapy; D001853:Bone Marrow / Q000187:drug effects* / Q000473:pathology; D005500:Follow-Up Studies; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D006111:Graves Disease / Q000139:chemically induced / Q000188:drug therapy; D006801:Humans; D008297:Male; D008713:Methimazole / Q000009:adverse effects* / Q000627:therapeutic use; D008775:Methylprednisolone / Q000627:therapeutic use; D010950:Plasma Cells / Q000187:drug effects* / Q000473:pathology; D013922:Thrombocytosis / Q000139:chemically induced* / Q000188:drug therapy; D016896:Treatment Outcome
D016179:Granulocyte Colony-Stimulating Factor; D008713:Methimazole; D008775:Methylprednisolone